Alnylam Pharmaceuticals, Inc. (ALNY) Financial Statements (2023 and Earlier)

Company Profile

Business Address 675 WEST KENDALL STREET
CAMBRIDGE, MA 02142
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2,4361,8741,5361,0841,6916271,081
Cash and cash equivalents820497547420645194181
Short-term investments1,6161,3789896641,045433900
Restricted cash and investments2200   
Receivables199102431934238
Inventory, net of allowances, customer advances and progress billings86755624   
Inventory86755624   
Other undisclosed current assets865608073402217
Total current assets:2,8092,6151,7161,2011,7656721,105
Noncurrent Assets
Operating lease, right-of-use asset232241221
Property, plant and equipment50246542532118211528
Long-term investments and receivables    14325252
Long-term investments    14325252
Restricted cash and investments4141154530150 
Other noncurrent assets6045189421
Total noncurrent assets:835792679374230591281
TOTAL ASSETS:3,6433,4072,3951,5751,9951,2631,387
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4694082471721019746
Accounts payable73525060285417
Accrued liabilities395356197113724229
Deferred revenue14912778
Debt  28    
Deferred rent credit   4
Deferred revenue and credits443517
Contract with customer, liability3
Other undisclosed current liabilities7850     
Total current liabilities:69658535317914413262
Noncurrent Liabilities
Long-term debt and lease obligation9574842763030150 
Long-term debt, excluding current maturities676191 3030150 
Operating lease, liability281293276
Liabilities, other than long-term debt25126332863546160
Deferred revenue and credits505858
Deferred revenue152225318
Contract with customer, liability0
Deferred rent credit   58
Other liabilities993895431
Other undisclosed noncurrent liabilities1,1511,058     
Total noncurrent liabilities:2,3591,806604938421160
Total liabilities:3,0552,391956273228343122
Stockholders' equity
Stockholders' equity attributable to parent5881,0161,4391,3021,7669201,265
Common stock1111111
Additional paid in capital6,0585,6445,2014,1753,9482,6102,506
Accumulated other comprehensive income (loss)(33)(44)(37)(33)(34)(33)4
Accumulated deficit(5,438)(4,585)(3,727)(2,841)(2,148)(1,657)(1,247)
Total stockholders' equity:5881,0161,4391,3021,7669201,265
TOTAL LIABILITIES AND EQUITY:3,6433,4072,3951,5751,9951,2631,387

Income Statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues84449322075904741
Revenue, net904741
Cost of revenue(140)(78)(25)(22)   
Cost of goods and services sold(115)(78)(25)(2)   
Gross profit:70441519553904741
Operating expenses(1,413)(1,243)(1,134)(867)(590)(472)(337)
Operating loss:(709)(828)(939)(815)(500)(425)(296)
Nonoperating income (expense)(143)(27)54549146
Investment income, nonoperating21233291286
Other nonoperating income (expense)(2)46114(3)60
Interest and debt expense(143)(84)     
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes 84(1)    
Loss from continuing operations before equity method investments, income taxes:(995)(856)(886)(761)(491)(410)(290)
Other undisclosed income from continuing operations before income taxes143 1    
Loss from continuing operations before income taxes:(852)(856)(885)(761)(491)(410)(290)
Income tax expense(1)(3)(1)(1)   
Net loss available to common stockholders, diluted:(853)(858)(886)(761)(491)(410)(290)

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(853)(858)(886)(761)(491)(410)(290)
Other comprehensive income (loss)10(7)(3)1(1)  
Comprehensive loss:(842)(865)(889)(760)(492)(410)(290)
Other undisclosed comprehensive loss, net of tax, attributable to parent     (38)(44)
Comprehensive loss, net of tax, attributable to parent:(842)(865)(889)(760)(492)(448)(334)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: